Effective polymer adjuvants for sustained delivery of protein subunit vaccines

Acta Biomaterialia

Volumn 14, Issue , 2015, Pages 104-114

  Adams, Justin R ^a   Haughney, Shannon L ^a   Mallapragada, Surya K ^a  

^a Iowa State University of Science and Technology   (United States)

Author keywords

Biocompatibility; Copolymer; Hydrogel; Immunochemistry; Pluronics

Indexed keywords

ANTIGENS; BIOCHEMISTRY; BLOCK COPOLYMERS; HYDROGELS; IMMUNE SYSTEM; PROTEINS; VACCINES;

BLOCK CO POLYMERS; IMMUNE RESPONSE; IN-VITRO; IN-VIVO; PENTABLOCK COPOLYMERS; PLURONICS; PROTEIN ANTIGENS; SUBUNIT VACCINE; THERMOGELLING; VACCINE ADJUVANTS;

BIOCOMPATIBILITY;

COPOLYMER; IMMUNOLOGICAL ADJUVANT; MACROGOL; OVALBUMIN; PENTABLOCK POLYVINYLPYRROLIDONE; POLOXAMER; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; METHACRYLIC ACID DERIVATIVE; NYLON; POLY(2-(DIETHYLAMINO)ETHYL METHACRYLATE); POLYMER; PROTEIN SUBUNIT; SUBUNIT VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ATOM TRANSFER RADICAL POLYMERIZATION; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG ANTIGENICITY; DRUG EFFICACY; DRUG STABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; HYDROGEL; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN SUBUNIT; PROTON NUCLEAR MAGNETIC RESONANCE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; ULTRAVIOLET SPECTROSCOPY; VACCINATION; ANIMAL; C57BL MOUSE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; FLUORESCENCE; METABOLISM; PHARMACOLOGY; POROSITY; SYNTHESIS; ULTRAVIOLET SPECTROPHOTOMETRY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CIRCULAR DICHROISM; DELAYED-ACTION PREPARATIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; IMMUNITY, HUMORAL; IMMUNIZATION; METHACRYLATES; MICE, INBRED C57BL; NYLONS; OVALBUMIN; POLYMERS; POROSITY; PROTEIN STABILITY; PROTEIN SUBUNITS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SPECTROPHOTOMETRY, ULTRAVIOLET; VACCINES, SUBUNIT;

EID: 84921878256     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.11.050     Document Type: Article

References (68)

1. Adams JR, Mallapragada SK. Enhancing the immune response through next generation polymeric vaccine adjuvants. Technology 2014:1-12. http://dx.doi.org/10.1142/S2339547814300017.
2. Zentner GM, Rathi R, Shih C, McRea JC, Seo M-H, Oh H, et al. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Controlled Release 2001;72:203-15. http://dx.doi.org/10.1016/S0168-3659(01)00276-0.
3. O'Hagan DT, Singh M, Gupta RK. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. Adv Drug Deliv Rev 1998;32:225-46. http://dx.doi.org/10.1016/S0169-409X(98)00012-X.
4. Tamber H, Johansen P, Merkle HP, Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 2005;57:357-76. http://dx.doi.org/10.1016/j.addr.2004.09.002.
5. Kabanov AV, Batrakova EV, Alakhov VY. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Controlled Release 2002;82:189-212. http://dx.doi.org/10.1016/S0168-3659(02)00009-3.
6. Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Controlled Release 2008;130:98-106. http://dx.doi.org/10.1016/j.jconrel.2008.04.013.
7. Determan M, Guo L, Lo C-T, Thiyagarajan P, Mallapragada S. PH- and temperature-dependent phase behavior of a PEO-PPO-PEO-based pentablock copolymer in aqueous media. Phys Rev E 2008;78. http://dx.doi.org/10.1103/PhysRevE.78.021802.
8. Coeshott CM, Smithson SL, Verderber E, Samaniego A, Blonder JM, Rosenthal GJ, et al. Pluronic® F127-based systemic vaccine delivery systems. Vaccine 2004;22:2396-405. http://dx.doi.org/10.1016/j.vaccine.2003.11.064.
9. Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997;388:860-2. http://dx.doi.org/10.1038/42218.
10. Determan MD, Cox JP, Mallapragada SK. Drug release from pH-responsive thermogelling pentablock copolymers. J Biomed Mater Res A 2007;81A:326-33. http://dx.doi.org/10.1002/jbm.a.30991.
11. Aucouturier J, Dupuis L, Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001;19:2666-72. http://dx.doi.org/10.1016/S0264-410X(00)00498-9.
12. Seong S-Y, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004;4:469-78. http://dx.doi.org/10.1038/nri1372.
13. Adams JR, Goswami M, Pohl NLB, Mallapragada SK. Synthesis and functionalization of virus-mimicking cationic block copolymers with pathogen-associated carbohydrates as potential vaccine adjuvants. RSC Adv 2014;4:15655-63. http://dx.doi.org/10.1039/C3RA47687A.
14. Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010;33:492-503. http://dx.doi.org/10.1016/j.immuni.2010.10.002.
15. Torres MP, Determan AS, Anderson GL, Mallapragada SK, Narasimhan B. Amphiphilic polyanhydrides for protein stabilization and release. Biomaterials 2007;28:108-16. http://dx.doi.org/10.1016/j.biomaterials.2006.08.047.
16. Determan AS, Graham JR, Pfeiffer KA, Narasimhan B. The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres. J Microencapsul 2006;23:832-43. http://dx.doi.org/10.1080/02652040601033841.
17. Jiang W, Gupta RK, Deshpande MC, Schwendeman SP. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 2005;57:391-410. http://dx.doi.org/10.1016/j.addr.2004.09.003.
18. Jones LS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J Biol Chem 2005;280:13406-14. http://dx.doi.org/10.1074/jbc.M500687200.
19. Kedl RM, Schaefer BC, Kappler JW, Marrack P. T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat Immunol 2002;3:27-32. http://dx.doi.org/10.1038/ni742.
20. Pulendran B, Oh JZ, Nakaya HI, Ravindran R, Kazmin DA. Immunity to viruses: learning from successful human vaccines. Immunol Rev 2013;255:243-55. http://dx.doi.org/10.1111/imr.12099.
21. Fu K, Klibanov AM, Langer R. Protein stability in controlled-release systems. Nat Biotechnol 2000;18:24-5. http://dx.doi.org/10.1038/71875.
22. Agarwal A, Unfer R, Mallapragada SK. Novel cationic pentablock copolymers as non-viral vectors for gene therapy. J Controlled Release 2005;103:245-58. http://dx.doi.org/10.1016/j.jconrel.2004.11.022.
23. Agarwal A, Unfer R, Mallapragada SK. Investigation of in vitro biocompatibility of novel pentablock copolymers for gene delivery. J Biomed Mater Res A 2007;81A:24-39. http://dx.doi.org/10.1002/jbm.a.30920.
24. Zhang B, Kanapathipillai M, Bisso P, Mallapragada S. Novel pentablock copolymers for selective gene delivery to cancer cells. Pharm Res 2009;26:700-13. http://dx.doi.org/10.1007/s11095-008-9813-y.
25. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Controlled Release 2012;161:505-22. http://dx.doi.org/10.1016/j.jconrel.2012.01.043.
26. Adams JR, Mallapragada SK. Novel atom transfer radical polymerization method to yield copper-free block copolymeric biomaterials. Macromol Chem Phys 2013;214:1321-5. http://dx.doi.org/10.1002/macp.201300034.
27. Zhang B, Mallapragada S. The mechanism of selective transfection mediated by pentablock copolymers. Part II. Nuclear entry and endosomal escape. Acta Biomater 2011;7:1580-7. http://dx.doi.org/10.1016/j.actbio.2010.11.033.
28. Zhang B, Jia F, Fleming MQ, Mallapragada SK. Injectable self-assembled block copolymers for sustained gene and drug co-delivery: an in vitro study. Int J Pharm 2012;427:88-96. http://dx.doi.org/10.1016/j.ijpharm.2011.10.018.
29. Determan MD, Cox JP, Seifert S, Thiyagarajan P, Mallapragada SK. Synthesis and characterization of temperature and pH-responsive pentablock copolymers. Polymer 2005;46:6933-46. http://dx.doi.org/10.1016/j.polymer.2005.05.138.
30. Zhang Z, Dong C, Yang C, Hu D, Long J, Wang L, et al. Stabilized copper(I) oxide nanoparticles catalyze azide-alkyne click reactions in water. Adv Synth Catal 2010;352:1600-4. http://dx.doi.org/10.1002/adsc.201000206.
31. Hahn MS, Miller JS, West JL. Three-dimensional biochemical and biomechanical patterning of hydrogels for guiding cell behavior. Adv Mater 2006;18:2679-84. http://dx.doi.org/10.1002/adma.200600647.
32. Seidi A, Ramalingam M, Elloumi-Hannachi I, Ostrovidov S, Khademhosseini A. Gradient biomaterials for soft-to-hard interface tissue engineering. Acta Biomater 2011;7:1441-51. http://dx.doi.org/10.1016/j.actbio.2011.01.011.
33. Chiu Y-C, Larson JC, Isom A, Brey EM. Generation of porous poly(ethylene glycol) hydrogels by salt leaching. Tissue Eng Part C Methods 2010;16:905-12. http://dx.doi.org/10.1089/ten.tec.2009.0646.
34. Cruise GM, Scharp DS, Hubbell JA. Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials 1998;19:1287-94. http://dx.doi.org/10.1016/S0142-9612(98)00025-8.
35. Revzin A, Russell RJ, Yadavalli VK, Koh W-G, Deister C, Hile DD, et al. Fabrication of poly(ethylene glycol) hydrogel microstructures using photolithography. Langmuir 2001;17:5440-7. http://dx.doi.org/10.1021/la010075w.
36. Agarwal A, Unfer RC, Mallapragada SK. Dual-role self-assembling nanoplexes for efficient gene transfection and sustained gene delivery. Biomaterials 2008;29:607-17. http://dx.doi.org/10.1016/j.biomaterials.2007.10.010.
37. Hu H-Y, Li Q, Cheng H-C, Du H-N. b-Sheet structure formation of proteins in solid state as revealed by circular dichroism spectroscopy. Biopolymers 2001;62:15-21. http://dx.doi.org/10.1002/1097-0282(2001)62:1〈15::AIDBIP30〉3.0.CO;2-J.
38. Huntington JA, Stein PE. Structure and properties of ovalbumin. J Chromatogr B Biomed Sci Appl 2001;756:189-98. http://dx.doi.org/10.1016/S0378-4347(01)00108-6.
39. Sun C, Liu Y, Liu J, Lu Y-J, Yu L, Zhang K, et al. Computational insights into processes underlying the amine-induced fluorescence quenching of a stimuli-responsive phenol-based hexameric foldamer host. J Org Chem 2014;79:2963-73. http://dx.doi.org/10.1021/jo500028t.
40. Gupta RK, Relyveld EH, Lindblad EB, Bizzini B, Ben-Efraim S, Gupta CK. Adjuvants - a balance between toxicity and adjuvanticity. Vaccine 1993;11:293-306. http://dx.doi.org/10.1016/0264-410X(93)90190-9.
41. Kohli AK, Alpar HO. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm 2004;275:13-7. http://dx.doi.org/10.1016/j.ijpharm.2003.10.038.
42. Slütter B, Plapied L, Fievez V, Alonso Sande M, des Rieux A, Schneider Y-J, et al. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J Controlled Release 2009;138:113-21. http://dx.doi.org/10.1016/j.jconrel.2009.05.011.
43. Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, Narasimhan B. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci 2009;98:1278-316. http://dx.doi.org/10.1002/jps.21523.
44. Sexton A, Whitney PG, Chong S-F, Zelikin AN, Johnston APR, De Rose R, et al. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules. ACS Nano 2009;3:3391-400. http://dx.doi.org/10.1021/nn900715g.
45. Ishii Y, Nakae T, Sakamoto F, Matsuo K, Matsuo K, Quan Y-S, et al. A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection. J Controlled Release 2008;131:113-20. http://dx.doi.org/10.1016/j.jconrel.2008.07.025.
46. Christie RJ, Findley DJ, Dunfee M, Hansen RD, Olsen SC, Grainger DW. Photopolymerized hydrogel carriers for live vaccine ballistic delivery. Vaccine 2006;24:1462-9. http://dx.doi.org/10.1016/j.vaccine.2005.05.048.
47. Matyjaszewski K, Xia J. Atom transfer radical polymerization. Chem Rev 2001;101:2921-90. http://dx.doi.org/10.1021/cr940534g.
48. Mallapragada SK, Narasimhan B. Immunomodulatory biomaterials. Int J Pharm 2008;364:265-71. http://dx.doi.org/10.1016/j.ijpharm.2008.06.030.
49. Demento SL, Siefert AL, Bandyopadhyay A, Sharp FA, Fahmy TM. Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines. Trends Biotechnol 2011;29:294-306. http://dx.doi.org/10.1016/j.tibtech.2011.02.004.
50. Bilati U, Allémann E, Doelker E. Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method - processing and formulation issues for enhanced entrapment efficiency. J Microencapsul 2005;22:205-14. http://dx.doi.org/10.1080/02652040400026442.
51. Desai MP, Hilfinger JM, Amidon GL, Levy RJ, Labhasetwar V. Immune response with biodegradable nanospheres and alum: studies in rabbits using staphylococcal enterotoxin B-toxoid. J Microencapsul 2000;17:215-25. http://dx.doi.org/10.1080/026520400288454.
52. Vermonden T, Censi R, Hennink WE. Hydrogels for protein delivery. Chem Rev 2012;112:2853-88. http://dx.doi.org/10.1021/cr200157d.
53. Szilagyi PG, Iwane MK, Humiston SE, et al. Time spent by primary care practices on pediatric influenza vaccination visits: implications for universal influenza vaccination. Arch Pediatr Adolesc Med 2003;157:191-5. http://dx.doi.org/10.1001/archpedi.157.2.191.
54. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002;54:37-51. http://dx.doi.org/10.1016/S0169-409X(01)00242-3.
55. Obst R, van Santen H-M, Mathis D, Benoist C. Antigen persistence is required throughout the expansion phase of a CD4+ T cell response. J Exp Med 2005;201:1555-65. http://dx.doi.org/10.1084/jem.20042521.
56. Storni T, Ruedl C, Renner WA, Bachmann MF. Innate immunity together with duration of antigen persistence regulate effector T cell induction. J Immunol 2003;171:795-801. http://dx.doi.org/10.4049/jimmunol.171.2.795.
57. Chung Y-I, Lee S-Y, Tae G. The effect of heparin on the gellation of Pluronic F-127 hydrogel. Colloids Surf Physicochem Eng Asp 2006;284-285:480-4. http://dx.doi.org/10.1016/j.colsurfa.2005.10.060.
58. Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000;18:927-74.
59. Sun H-X, Pan H-J. Immunological adjuvant effect of Glycyrrhiza uralensis saponins on the immune responses to ovalbumin in mice. Vaccine 2006;24:1914-20. http://dx.doi.org/10.1016/j.vaccine.2005.10.040.
60. Huntimer L, Wilson Welder JH, Ross K, Carrillo-Conde B, Pruisner L, Wang C, et al. Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses. J Biomed Mater Res B Appl Biomater 2013;101B:91-8. http://dx.doi.org/10.1002/jbm.b.32820.
61. O'Hagan DT, Jeffery H, Roberts MJJ, McGee JP, Davis SS. Controlled release microparticles for vaccine development. Vaccine 1991;9:768-71. http://dx.doi.org/10.1016/0264-410X(91)90295-H.
62. Gordon S, Teichmann E, Young K, Finnie K, Rades T, Hook S. In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery. Eur J Pharm Sci 2010;41:360-8. http://dx.doi.org/10.1016/j.ejps.2010.07.004.
63. Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol Biosci 2006;6:623-33. http://dx.doi.org/10.1002/mabi.200600069.
64. Gong C-Y, Shi S, Peng X-Y, Kan B, Yang L, Huang M-J, et al. Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity. Growth Factors 2009;27:377-83. http://dx.doi.org/10.3109/08977190903159938.
65. Wu Y, Wei W, Zhou M, Wang Y, Wu J, Ma G, et al. Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization. Biomaterials 2012;33:2351-60. http://dx.doi.org/10.1016/j.biomaterials.2011.11.068.
66. Julie Westerink MA, Louise Smithson S, Srivastava N, Blonder J, Coeshott C, Rosenthal GJ. ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoid. Vaccine 2001;20:711-23. http://dx.doi.org/10.1016/S0264-410X(01)00423-6.
67. Nochi T, Yuki Y, Takahashi H, Sawada S, Mejima M, Kohda T, et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 2010;9:572-8. http://dx.doi.org/10.1038/nmat2784.
68. O'Hagan DT, Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines 2003;2:269-83. http://dx.doi.org/10.1586/14760584.2.2.269.